Histological techniques, such as immunohistochemistry (IHC) and in situ hybridization (ISH), are used to identify and visualize potential therapeutic targets. These methods allow researchers to detect the presence and distribution of specific proteins and nucleic acids within tissue sections. Advances in molecular histology and high-throughput screening have further enhanced the ability to identify novel therapeutic targets.
